should i try glp 1 Microdosing GLP-1: You It? Benefits & Risks Should I Try GLP-1 Medications?
Description
Preclinical studies have evaluated the therapeutic potential of GLP-1 based polypharmacology for the treatment of obesity and diabetes
The opportunity for this miracle drug seems limitless
Commercial availability would likely follow in early 2027, pending approval and standard launch timelines
February 2024
In 2012, a group of scientists affiliated with the pharmaceutical company Novo Nordisk formulated semaglutide to address the needs of individuals with type 2 diabetes
Indication expansion, such as approvals for additional metabolic and cardiovascular conditions, is broadening patient access and driving adoption
